Legal Representation
Attorney
Leon R. Legleiter
USPTO Deadlines
Next Deadline
2019 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250819)
Due Date
August 19, 2031
Grace Period Ends
February 19, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 19, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 19, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 30, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 30, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 30, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 28, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 30, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 30, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 30, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 2, 2024 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 7, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Dec 20, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 20, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Oct 2, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 2, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 2, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 15, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 15, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 6, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 15, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 15, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Dec 20, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 19, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 6, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 15, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 14, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer
Classification
International Classes
005